Susceptibility of Clostridium difficile to LY146032.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001414:Bacitracin / Q000494:pharmacology; D003013:Clostridium / Q000187:drug effects*; D017576:Daptomycin; D005672:Fusidic Acid / Q000494:pharmacology; D006801:Humans; D008795:Metronidazole / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010455:Peptides / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010455:Peptides; D001414:Bacitracin; D008795:Metronidazole; D005672:Fusidic Acid; D014640:Vancomycin; D017576:Daptomycin